Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety Evaluation of Vi-sealer — Stella

Home/Benign Gynecologic Neoplasm/Efficacy and Safety Evaluation of Vi-sealer

View on ClinicalTrials.gov

Recruiting

Back to Benign Gynecologic Neoplasm trials

Efficacy and Safety Evaluation of Vi-sealer

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

South Korea

CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do

Key details

Sponsor

Hyun Park

Enrollment target

~280 participants

Started

January 2023

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 65 Years

Sex

Female only

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.